Patent · US Active

ST2L antagonists and methods of use

US10450377B2 · kind B2 · utility

1Cited by
3References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 15, 2018
Grant dateOct 22, 2019
Priority date
Expiry dateMar 15, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to ST2L antagonists, polynucleotides encoding the antagonists or fragments thereof, and methods of making and using the foregoing.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.